Massachusetts Institute of Technology’s Procept Biorobotics PRCT Stock Holding History

Massachusetts Institute of Technology’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24,102	Closed	-$1.47M	–	6
2024 Q2	$1.47M	Hold	24,102	–	–	0.23%	4
2024 Q1	$1.19M	Hold	24,102	–	–	0.21%	5
2023 Q4	$1.01M	Hold	24,102	–	–	0.19%	7
2023 Q3	$791K	Hold	24,102	–	–	0.14%	6
2023 Q2	$852K	Hold	24,102	–	–	0.13%	9
2023 Q1	$684K	Hold	24,102	–	–	0.11%	8
2022 Q4	$1M	Buy	24,102 +16,068	+200%	+$690K	0.17%	6
2022 Q3	$333K	Buy	+8,034	New	+$320K	0.06%	7

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Massachusetts Institute of Technology's PRCT Position: Q3 2024 in Review

Massachusetts Institute of Technology sold out of Procept Biorobotics (PRCT) in Q3 2024, closing a stake of 24,102 shares — an estimated $1.47M sold.

Massachusetts Institute of Technology first reported a position in PRCT in Q3 2022 and held it in 8 quarters. The position peaked at $1.47M in Q2 2024. 250 funds tracked by Wall St. Rank hold PRCT as of Q3 2024.

Massachusetts Institute of Technology reported no remaining Procept Biorobotics position as of Q3 2024 after selling out during the quarter.
Massachusetts Institute of Technology sold 24,102 Procept Biorobotics shares in Q3 2024, an estimated $1.47M.
Massachusetts Institute of Technology first reported a position in Procept Biorobotics in Q3 2022 and held it in 8 quarters.
Massachusetts Institute of Technology's Procept Biorobotics position peaked at $1.47M in Q2 2024.
250 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2024.

Based on Massachusetts Institute of Technology's 13F filing for Q3 2024, filed 14 Nov 2024.